Have a feature idea you'd love to see implemented? Let us know!

GMED Globus Medical PE ratio, current and historical analysis

The price-to-earnings ratio for Globus Medical stock stands at 105.63 as of Feb 21, 2025. This is calculated based on the current EPS of $0.76 and the stock price of $80.28 per share. A decrease of 28% has been recorded in the PE ratio compared to the average of 147.3 of the past four quarters.

GMED PE ratio history

How has GMED's PE ratio performed in the past

Over the last ten years, the average PE ratio of Globus Medical has been 45.96. The current 105.63 price-to-earnings ratio is 130% more than the historical average. In the past ten years, GMED's PE ratio reached its highest point in the Jun 2024 quarter at 273.96, with a price of $68.49 and an EPS of $0.25. The Sep 2016 quarter saw the lowest point at 18.35, with a price of $22.57 and an EPS of $1.23.

Today
105.63
Average
45.96
Median
36.37
Minimum
18.35
Maximum
273.96

Globus Medical PE ratio by year

Maximum annual increase: 122.6% in 2024

Maximum annual decrease: -26.29% in 2018

Year PE ratio PE change Price EPS
2024 108.83 122.6% $82.71 $0.76
2023 48.89 24.4% $53.29 $1.09
2022 39.3 -19.43% $74.27 $1.89
2021 48.78 -22.21% $72.2 $1.48
2020 62.71 67.23% $65.22 $1.04
2019 37.5 38.63% $58.88 $1.57
2018 27.05 -26.29% $43.28 $1.6
2017 36.7 61.25% $41.1 $1.12
2016 22.76 -2.65% $24.81 $1.09
2015 23.38 -3.63% $27.82 $1.19
2014 24.26 -11.04% $23.77 $0.98
2013 27.27 113.21% $20.18 $0.74
2012 12.79 N/A $10.49 $0.82
2011 N/A N/A N/A $0.69
2010 N/A N/A N/A $0.61

Globus Medical PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Dec 2024 108.83 -5.69% $82.71 $0.76
Sep 2024 115.39 -57.88% $71.54 $0.62
Jun 2024 273.96 201.32% $68.49 $0.25
Mar 2024 90.92 85.97% $53.64 $0.59
Dec 2023 48.89 54.62% $53.29 $1.09
Sep 2023 31.62 8.32% $49.65 $1.57
Jun 2023 29.19 3.58% $59.54 $2.04
Mar 2023 28.18 -28.3% $56.64 $2.01
Dec 2022 39.3 1.6% $74.27 $1.89
Sep 2022 38.68 5.42% $59.57 $1.54
Jun 2022 36.69 -30.38% $56.14 $1.53
Mar 2022 52.7 8.04% $73.78 $1.4
Dec 2021 48.78 19.06% $72.2 $1.48
Sep 2021 40.97 -2.24% $76.62 $1.87
Jun 2021 41.91 -16.41% $77.53 $1.85

GMED average PE ratio chart

What is the average PE ratio of GMED for the past years

The current PE ratio of GMED is above its 3, 5 and 10-year historical averages.

3-year avg
74.53
5-year avg
63.59
10-year avg
45.96
15-year avg
N/A

GMED PE vs peers

What is GMED's PE ratio compared to its peers

GMED's PE ratio is above its peer stock SYK.

Stock name PE ratio Market cap
SYK Stryker Corp 48.7 $146.06B
GMED Globus Medical Inc 105.63 $11.04B
OFIX Orthofix Medical Inc N/A $685.94M
ATEC Alphatec Holdings Inc N/A $1.5B

Frequently asked questions

What is Globus Medical's PE ratio?

The price to earnings ratio for GMED stock as of Feb 21, 2025, stands at 105.63.

What is the 3-year average PE ratio for Globus Medical (GMED)?

Over the last 3 years, the average PE ratio for GMED stock is 74.53.

What is the 5-year average PE ratio for Globus Medical (GMED)?

Over the last 5 years, the average PE ratio for GMED stock is 63.59.

What is the highest PE ratio for GMED?

In the last ten years, the Jun 2024 quarter recorded the highest quarterly PE ratio at 273.96.

How does the current PE ratio for GMED compare to its historical average?

The current price to earnings ratio of GMED is 130% higher than the 10-year historical average.

Why is Globus Medical's PE ratio so high?

GMED's PE ratio of 105.63 is considered high because the company's stock price is trading at a higher multiple of earnings.

How is GMED's PE ratio calculated (Globus Medical PE ratio formula)?

The P/E ratio is calculated by taking the latest stock price and dividing it by the earnings per share(EPS) for the last 12 months. As of today (Feb 21, 2025), Globus Medical's stock price is $80.28. The earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $0.76. Therefore, Globus Medical's price to earnings ratio for today is 105.63. PE RATIO(105.63) = STOCK PRICE($80.28) / TTM EPS($0.76)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.